About DifGen
DifGen is a company based in Miramar, USA. It operates as a Direct-to-Consumer (D2C) and B2B2C. DifGen has completed 2 acquisitions, including Aveva and KriGen Pharmaceuticals. DifGen offers products and services including Generic Pharmaceuticals, Branded Generics, and Transdermal Systems.
- Headquarter Miramar, USA
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Aveva
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DifGen
DifGen offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals, Branded Generics, and Transdermal Systems.
Generic drugs are produced for affordable healthcare solutions.
Branded generics are offered for accessible medical treatments.
Advanced transdermal patches are manufactured for drug delivery.
People of DifGen
Unlock access to complete
Funding Insights of DifGen
Detailed funding history for DifGen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DifGen
DifGen has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aveva and KriGen Pharmaceuticals.
Investment portfolio details for DifGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Injectable pharmaceuticals are manufactured by KriGen Pharmaceuticals as a CDMO.
|
Locked | Locked | 2018 | Locked | |
|
Drugs for multiple therapeutic areas are manufactured by Aveva.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for DifGen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - DifGen
Detailed financials for DifGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Difgen Comparisons
Peer comparison for DifGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DifGen
Detailed competitors of DifGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Difgen
Complete news archive for DifGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DifGen
DifGen Pharmaceuticals is involved in the development, manufacturing, and supply of high-quality generic and branded generic products. The company operates across various dosage forms, focusing on complex generics and advanced transdermal systems through its subsidiary, Aveva Drug Delivery Systems Inc. Expertise is maintained in research and development, regulatory compliance, and supply chain management to ensure access to essential medicines. Solutions are provided for healthcare sectors, emphasizing affordability and innovation to improve patient outcomes globally.
DifGen offers Generic Pharmaceuticals, Branded Generics, and Transdermal Systems.
DifGen has made 2 acquisitions, including Aveva, and KriGen Pharmaceuticals.